BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.06 per share for the quarter. BrightSpring Health Services has set its FY 2024 guidance at EPS.Parties interested in registering for the company’s conference call can do so using this link.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last posted its quarterly earnings results on Thursday, February 29th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.21). The firm had revenue of $2.38 billion for the quarter, compared to the consensus estimate of $2.36 billion. BrightSpring Health Services’s quarterly revenue was up 20.5% compared to the same quarter last year. On average, analysts expect BrightSpring Health Services to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
BrightSpring Health Services Stock Performance
BTSG opened at $10.91 on Tuesday. BrightSpring Health Services has a 1-year low of $7.85 and a 1-year high of $12.14. The stock has a 50 day moving average price of $9.86. The company has a debt-to-equity ratio of 5.73, a quick ratio of 0.84 and a current ratio of 1.17.
Insider Transactions at BrightSpring Health Services
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on BTSG shares. Deutsche Bank Aktiengesellschaft upgraded BrightSpring Health Services from a “hold” rating to a “buy” rating and set a $11.50 price target for the company in a research report on Tuesday, February 27th. Morgan Stanley started coverage on shares of BrightSpring Health Services in a report on Tuesday, February 20th. They issued an “overweight” rating and a $18.00 price target on the stock. HSBC assumed coverage on shares of BrightSpring Health Services in a research note on Wednesday, March 6th. They set a “buy” rating and a $13.00 price objective for the company. SVB Leerink began coverage on BrightSpring Health Services in a research report on Tuesday, February 20th. They set an “outperform” rating and a $15.00 price objective for the company. Finally, The Goldman Sachs Group lowered their target price on BrightSpring Health Services from $26.00 to $23.00 and set a “buy” rating on the stock in a report on Monday, March 4th. Eleven research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $15.75.
View Our Latest Stock Analysis on BTSG
About BrightSpring Health Services
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
See Also
- Five stocks we like better than BrightSpring Health Services
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- The 3 Hottest Insiders Buys This Month
- Conference Calls and Individual Investors
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- The “How” and “Why” of Investing in 5G Stocks
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.